These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1465897)

  • 1. Treatment of hypercholesterolemia and prevention of coronary artery disease after heart transplantation by combination of low-dose simvastatin and HELP-LDL-apheresis.
    Wenke K; Thiery J; Arndtz N; Meiser BM; Seidel D; Reichart B
    Transplant Proc; 1992 Dec; 24(6):2674-6. PubMed ID: 1465897
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Maximal therapy of hypercholesterolemia in coronary heart disease].
    Thiery J; Armstrong V; Bosch T; Eisenhauer T; Schuff-Werner P; Seidel D
    Ther Umsch; 1990 Jun; 47(6):520-9. PubMed ID: 2375008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating hypercholesterolemia aggressively.
    Wilson CS
    Nebr Med J; 1996 Jan; 81(1):3-4. PubMed ID: 8584066
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up].
    Wenke K; Thiery J; Meiser B; Arndtz N; Seidel D; Reichart B
    Z Kardiol; 1995 Feb; 84(2):130-6. PubMed ID: 7717016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
    French JK; White HD; Greaves SC
    N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
    Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.
    Feldman T; Koren M; Insull W; McKenney J; Schrott H; Lewin A; Shah S; Sidisin M; Cho M; Kush D; Mitchel Y
    Am J Cardiol; 2004 Jun; 93(12):1481-6. PubMed ID: 15194017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Can hyperlipidemia after heart transplantation be optimally and safely treated?].
    Wenke K; Thiery J; Arndtz N; Seidel D; Reichart B
    Helv Chir Acta; 1994 Dec; 60(6):1163-8. PubMed ID: 7875999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation.
    Jaeger BR; Meiser B; Nagel D; Uberfuhr P; Thiery J; Brandl U; Brückner W; von Scheidt W; Kreuzer E; Steinbeck G; Reichart B; Seidel D
    Circulation; 1997 Nov; 96(9 Suppl):II-154-8. PubMed ID: 9386091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia].
    Tomei R; Rossi L; Carbonieri E; Franceschini L; Cemin C; Ghebremariam-Tesfau K; Zardini P
    Cardiologia; 1993 Dec; 38(12):773-8. PubMed ID: 8200011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
    Elam MB; Cushman W; Applegate WB; Heimberg M
    Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
    [No Abstract]   [Full Text] [Related]  

  • 13. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
    Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A
    Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine.
    Vanhaecke J; Van Cleemput J; Van Lierde J; Daenen W; De Geest H
    Transplantation; 1994 Jul; 58(1):42-5. PubMed ID: 8036706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maximal treatment of hypercholesteremia: what is possible?].
    Thiery J
    Arzneimittelforschung; 1990 Mar; 40(3A):383-8. PubMed ID: 2185771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.
    Kroon AA; van Asten WN; Stalenhoef AF
    Ann Intern Med; 1996 Dec; 125(12):945-54. PubMed ID: 8967704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia.
    Cantarell C; Bonal J; Sierra C; Pastor C; Lauzurica R; Capdevila L
    Transplant Proc; 1995 Aug; 27(4):2222-3. PubMed ID: 7652781
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
    Geiss HC; Otto C; Parhofer KG
    Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density-lipoprotein apheresis.
    Richter WO; Schwandt P
    Lancet; 1995 Jul; 346(8967):116-7. PubMed ID: 7677855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.